The EMJ Podcast: Insights For Healthcare Professionals EMJ

In this episode, Jonathan is joined by Adam Brown, Rheumatologist at the Cleveland Clinic in Ohio, USA. They discuss Brown’s unconventional teaching practices and how he has been awarded the teacher of the year several times at the Cleveland Clinic. They also delve into the history of rheumatology, focusing on specific rheumatological conditions such as gout, and his recent talk at the American College of Rheumatology (ACR) meeting. 

Use the following links to navigate the key topics discussed in this episode: 

(00:00)-Introduction 

(02:51)-Adam’s path into rheumatology 

(06:44)-Travel and learnings from being abroad 

(08:47)-Surfing in Australia  

(11:37)-The King’s disease 

(18:55)-Online rheumatology resources 

(20:45)-Rheumatology made ridiculously simple 

(27:04)-The societal impacts of plagues and pandemics throughout history  

(35:24)-Whipple disease
(39:35)-Three wishes for the future of healthcare 

Giovanni Adami, Rheumatologist at the University of Verona, Italy, joins Jonathan to discuss a range of topics, from metabolic bone disease to rheumatoid arthritis and osteoporosis, and provide an overview of causes and symptoms, as well as treatments. They further dive into the impact of rheumatoid arthritis on patients and their quality of life, as well as the association between air pollution and rheumatoid arthritis flares. 

 

Use the following timestamps to navigate the topics discussed in this episode: 

(00:00)-Introduction


(02:30)-Adami's origin story


(03:14)-Experiences from Alabama, USA, and research carried out there 

(06:36)-Osteoporosis and bisphosphonates 

(07:05)-Fragility fractures in diseases requiring glucocorticoids 

(10:14)-Metabolic bone disease and its causes 

(13:24)-How to reduce the number of patients with metabolic bone disease 

(14:24)-Incidence of hip fracture worldwide 

(16:29)-Positive effects of TNF-α inhibitors 

(19:21)-Benefits of Vitamin D for older patients 

(20:04)-Links between rheumatoid arthritis and osteoporosis 

(23:13)-Arthritis types and causes 

(25:57)-Gout 

(28:55)-Impact of arthritis diagnosis on patients 

(30:54)-Association between air pollution and disease activity 

(36:47)-Three wishes for the future of healthcare 

In this third podcast, Ali Mobasheri and Daniel White focus on late-stage OA, when the burden is high for both the individual and society. Our two speakers advise patients, caregivers, and physicians about how OA disease should be managed in the end stages, when to engage patients for surgical options, and whether this is appropriate or not according to other comorbidities.
This content has been supported by Viatris

On this episode, Jonathan is joined by Noel Morgan, Professor of Endocrine Pharmacology, University of Exeter, UK. The pair discuss Morgan’s extensive research in diabetes, including his research on islet biology and signalling mechanisms regulating pro-inflammatory and anti-inflammatory processes in β-cells in Type 1 diabetes. They further discuss areas of research that excite and frustrate him, how we can change beliefs and behaviours associated with diabetes, and the future of diabetes research.
 
Use the following timestamps to navigate the topics discussed in this episode:  

(00:00)-Introduction
(02:00)-Morgan's origin story

(03:30)-Experiences from Nashville, USA

(06:00)-Islet biology

(08:00)-Insulin secretion control

(12:25)-Aetiology and differences between Type 1 and Type 2 diabetes

(15:10)-The largest collection of rare pancreas samples in the world

(17:50)-Different ‘types’ of Type 1 diabetes

(20:15)-Pro-insulin

(22:35)-To B or not to B?

(24:35)-Rituximab

(26:00)-Dorothy Hodgkin Lecture

(28:00)-The global obesity epidemic and changing behaviour

(31:45)-The war on obesity

(33:40)-A longer, unhealthy life?

(34:45)-Exciting topics and immunotherapy

(36:50)-Three wishes

This informative podcast spotlights the current treatment landscape of hypertrophic cardiomyopathy (HCM), detailing typical diagnosis and outlining the use of echocardiography for obstructive HCM.
This podcast was sponsored by Myokardia and Bristol Myers Squibb.

In this episode, Jonathan is joined by Chris Wincup, Versus Arthritis Clinical Research Fellow in Rheumatology, Department of Rheumatology, University College London, UK. They discuss the current treatments for systemic lupus erythematosus (SLE), as well as symptoms. They also consider mental health in patients with SLE, and the effect that the COVID-19 pandemic has had on patients with SLE and autoimmune diseases.